CA Final · Integrated Business Solutions (Multidisciplinary Case Study with Strategic Management) · Corporate and Economic Laws
Case: Sundaram Pharma Ltd, a listed company, proposes to buy back its own equity shares out of free reserves. Its paid-up capital is Rs 40 crore and free reserves are Rs 60 crore, so paid-up capital plus free reserves are Rs 100 crore. The board wants a buy-back via a board resolution only. Under the Companies Act, 2013, up to what amount of buy-back can be authorised by the board alone without a shareholders' special resolution?
The board alone can authorise a buy-back up to 10% of the aggregate paid-up equity capital and free reserves, which is Rs 10 crore here. Anything above that, up to the 25% overall limit of Rs 25 crore, requires a special resolution of shareholders.
- ARs 10 crore (10% of paid-up capital and free reserves)Correct
- BRs 25 crore
- CRs 4 crore
- DRs 50 crore
Explanation
A board resolution suffices if the buy-back is up to 10% of the total paid-up equity capital and free reserves: 10% of Rs 100 crore equals Rs 10 crore. Beyond this, up to 25% (Rs 25 crore) needs a special resolution. Rs 25 crore is therefore the overall cap, not the board's limit. Rs 4 crore wrongly takes 10% of paid-up capital alone.
Did you get it right without looking?
One question tells you little. A timed set on Corporate and Economic Laws shows your real accuracy, how long you take and where you lose marks.
More Corporate and Economic Laws questions
- Case: Vihaan Steels Ltd, a public company, had Rs 10 crore paid-up capital and a creditor, Orbit Metals, owed Rs 3 crore. Vihaan's bank, Nat…
- Case: Vihaan Pharma Ltd imports raw materials priced in US dollars. Its CFO says a rise in the repo rate and a depreciating rupee will both …
- Case: Orion Steels Ltd, a company with a Rs 500 crore turnover, also has a related Competition Commission inquiry. Orion holds a 70% market …
- Case: Rohini Pharma Ltd, an Indian company, has a foreign promoter, Helix GmbH, holding 60%. Rohini plans to acquire 30% of a Singapore phar…
- Case: Bharat Pharma Ltd, a company in Hyderabad, receives a foreign remittance from a US investor for Rs 40 crore in exchange for equity sha…
- Case: Kaveri Agro Foods Ltd, an unlisted public company, has paid-up capital of Rs 40 crore. Its Board wants to issue shares to a few identi…